CIBC Bank USA’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,770
Closed -$457K 263
2016
Q3
$457K Buy
5,770
+1,192
+26% +$96.8K 0.07% 162
2016
Q2
$382K Sell
4,578
-830
-15% -$73.7K 0.06% 167
2016
Q1
$498K Sell
5,408
-3,965
-42% -$358K 0.09% 134
2015
Q4
$949K Sell
9,373
-2,184
-19% -$227K 0.17% 87
2015
Q3
$1.14M Sell
11,557
-488
-4% -$54.2K 0.21% 71
2015
Q2
$1.41M Buy
12,045
+310
+3% +$33.9K 0.23% 65
2015
Q1
$1.15M Sell
11,735
-3,885
-25% -$394K 0.2% 74
2014
Q4
$1.47M Buy
15,620
+1,645
+12% +$170K 0.26% 64
2014
Q3
$1.49M Sell
13,975
-1,190
-8% -$117K 0.3% 57
2014
Q2
$1.26M Sell
15,165
-4,875
-24% -$379K 0.24% 71
2014
Q1
$1.42M Sell
20,040
-1,445
-7% -$113K 0.29% 64
2013
Q4
$1.61M Buy
21,485
+3,590
+20% +$250K 0.36% 58
2013
Q3
$1.13M Sell
17,895
-18,730
-51% -$1.12M 0.27% 79
2013
Q2
$1.88M Buy
+36,625
New +$1.91M 0.11% 131

Other funds holding GILD

CIBC Bank USA's GILD Position: Q4 2016 in Review

CIBC Bank USA sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 5,770 shares — an estimated $457K sold.

CIBC Bank USA first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $1.88M in Q2 2013. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • CIBC Bank USA reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • CIBC Bank USA sold 5,770 Gilead Sciences shares in Q4 2016, an estimated $457K.
  • CIBC Bank USA first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • CIBC Bank USA's Gilead Sciences position peaked at $1.88M in Q2 2013.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on CIBC Bank USA's 13F filing for Q4 2016, filed 24 Jan 2017.